Direct intraoperative micromethod for hormone measurements of pituitary tissue in Cushing's disease.
BACKGROUND
During transsphenoidal surgery (TSS) for Cushing's disease, the surgeon depends on experience to find minute adenomas. Cytological slide preparations or frozen sections, even when successful, are not specific concerning the hormone activity. In an attempt to improve accurate localization of minute ACTH adenomas, we evaluated a new intraoperative method of ACTH measurements in adenoma and anterior lobe microsamples. As most ACTH adenomas are monohormonal, the possible benefit of a GH measurement was investigated.


METHODS
We included pituitary tissue of 32 patients, 22 with Cushing's disease and 10 endocrine inactive pituitary adenomas as control. All patients underwent TSS by one surgeon. Preoperative data, intraoperative and perioperative hormone measurements of homogenized, weighed pituitary tissue samples, and histological findings are presented.


RESULTS
In ACTH adenomas, the median ACTH content was found to be 1,688 ng/mg, minimum 345 ng/mg. The median GH was measured at 36 ng/mg. Anterior lobe tissue contained median 80 ng ACTH/mg, maximum 279 ng/mg. Median GH was 2,200 ng/mg. In hormonally inactive adenomas ACTH was less than 0.1 ng/mg, median GH was 5.5 ng/mg. There was no overlap of ACTH content in the tissues investigated. Therefore, by adopting 300 ng ACTH/mg as a cutoff level, a clear discrimination is given. Additional GH measurements are not necessary.


CONCLUSIONS
This new intraoperative method permits a clear differentiation between adenoma and pituitary tissue. In addition to intraoperative cytology and histology, this method can serve as a specific proof that the ACTH adenoma has been identified during surgery. This may be valuable in difficult cases with unclear intraoperative findings, especially after previously negative exploration.
Flitsch
J
J
Clinic of Neurosurgery, University Hospital Eppendorf (UKE), Hamburg, Germany.
Knappe
U J
UJ
Lüdecke
D K
DK
D000236:Adenoma / Q000737:chemistry / Q000473:pathology / Q000601:surgery*; D000324:Adrenocorticotropic Hormone / Q000032:analysis*; D001707:Biopsy, Needle / Q000295:instrumentation; D003480:Cushing Syndrome / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D019382:Human Growth Hormone / Q000032:analysis; D006801:Humans; D008279:Magnetic Resonance Imaging; D008866:Microsurgery / Q000295:instrumentation; D010902:Pituitary Gland / Q000737:chemistry / Q000473:pathology; D010911:Pituitary Neoplasms / Q000737:chemistry / Q000473:pathology / Q000601:surgery*
D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone